Gritstone Bio Inc (NASDAQ:GRTS) currently has a daily average trading volume of 2.09M but it saw 122315764 shares traded in last market. With a market cap of 7.33M USD, the company’s current market price of $0.06 came falling about -68.70 while comparing to the previous closing price of $0.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.33 and as low as $0.18. In the recent trading on the day, stock has struck highest price mark of $0.0558 while lowest mark touched by it was $0.082.
Taking a look at 20-day trading activity of Gritstone Bio Inc (GRTS) gives us an average price of $0.4245, while its current price level is -98.14% below from 52-week high level whereas it is -65.75% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4672 while that of 200 days or SMA-200 reads an average of $1.2393. A closer look into the stock’s movement over the week reveals that its volatility is standing at 19.44% during that period while stretching the period over a month that decreases to 18.91%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 17.32 which implies that the stock is in oversold territory.
Over the week, GRTS’s stock price is moving -68.95% down while it is -87.38% when we observe its performance for the past one month. Year-to-date it is -96.96% down and over the past year, the stock is showing a downside performance of -97.82%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.33 beat the consensus estimate of -0.33 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of -0.17 while estimate for next year EPS is -0.84. In next quarter, company is expected to be making quarterly sales of $530k as analysts are expecting the sales for current fiscal year at $5.6M and seeing the company making $2.41M in sales next year. Moreover, analysts are in estimates of $2.32M for current-quarter revenue.
Currently, Gritstone Bio Inc’s total number of outstanding shares is 118.11M. Company’s return on investment (ROI) stands at -113.20% and return on equity (ROE) at -201.94%. Stock’s beta reads 0.53. Stock has a price to book (P/B) ratio of 0.33 while price to sale or P/S ratio amounts to 14.67. Its return on asset (ROA) is -72.86% on average.
